These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21593139

  • 1. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA.
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [Abstract] [Full Text] [Related]

  • 2. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F.
    Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
    [Abstract] [Full Text] [Related]

  • 3. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855
    [Abstract] [Full Text] [Related]

  • 4. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
    Hart M, Nolte E, Wach S, Szczyrba J, Taubert H, Rau TT, Hartmann A, Grässer FA, Wullich B.
    Mol Cancer Res; 2014 Feb 05; 12(2):250-63. PubMed ID: 24337069
    [Abstract] [Full Text] [Related]

  • 5. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L.
    Mol Cancer; 2016 Nov 10; 15(1):70. PubMed ID: 27832783
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA expression profiling in prostate cancer.
    Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T.
    Cancer Res; 2007 Jul 01; 67(13):6130-5. PubMed ID: 17616669
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H.
    Prostate; 2014 May 01; 74(7):756-67. PubMed ID: 24644030
    [Abstract] [Full Text] [Related]

  • 8. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 01; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

  • 9. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
    Park YA, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    Gynecol Oncol; 2012 Jan 01; 124(1):125-33. PubMed ID: 22015043
    [Abstract] [Full Text] [Related]

  • 10. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression.
    Murata T, Takayama K, Katayama S, Urano T, Horie-Inoue K, Ikeda K, Takahashi S, Kawazu C, Hasegawa A, Ouchi Y, Homma Y, Hayashizaki Y, Inoue S.
    Prostate Cancer Prostatic Dis; 2010 Dec 01; 13(4):356-61. PubMed ID: 20820187
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X, Tang H.
    Cell Res; 2009 Jul 01; 19(7):828-37. PubMed ID: 19546886
    [Abstract] [Full Text] [Related]

  • 12. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O.
    Cancer Res; 2011 Mar 01; 71(5):1956-67. PubMed ID: 21343391
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, Lu PJ.
    Oncogene; 2009 Sep 24; 28(38):3360-70. PubMed ID: 19597470
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.
    Ma S, Chan YP, Kwan PS, Lee TK, Yan M, Tang KH, Ling MT, Vielkind JR, Guan XY, Chan KW.
    Cancer Res; 2011 Jan 15; 71(2):583-92. PubMed ID: 21224345
    [Abstract] [Full Text] [Related]

  • 15. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J.
    Clin Cancer Res; 2009 Apr 01; 15(7):2281-90. PubMed ID: 19318487
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M.
    Cancer Res; 2010 Mar 15; 70(6):2339-49. PubMed ID: 20215506
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 15; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G, Butz H, Delhove J, Igreja S, Chahal HS, Zivkovic V, McKay T, Patócs A, Grossman AB, Korbonits M.
    Am J Physiol Endocrinol Metab; 2012 Sep 15; 303(6):E708-19. PubMed ID: 22811466
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
    Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X, Tang H.
    FEBS J; 2012 Apr 15; 279(7):1252-60. PubMed ID: 22325466
    [Abstract] [Full Text] [Related]

  • 20. Widespread deregulation of microRNA expression in human prostate cancer.
    Ozen M, Creighton CJ, Ozdemir M, Ittmann M.
    Oncogene; 2008 Mar 13; 27(12):1788-93. PubMed ID: 17891175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.